Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer

Shoji Nagao, Tadaaki Nishikawa, Tatsuya Hanaoka, Akira Kurosaki, Norihiro Iwasa, Kosei Hasegawa, Keiichi Fujiwara

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences